Drug-induced hepatotoxicity.
Lee
William M
WM
Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9151, USA. william.lee@utsouthwestern.edu
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001577:Benzophenones / Q000009:adverse effects; D001969:Bromobenzenes / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury; D002839:Chromans / Q000009:adverse effects; D017277:Drug Approval; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008103:Liver Cirrhosis / Q000378:metabolism; D008107:Liver Diseases / Q000473:pathology; D008111:Liver Function Tests; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010600:Pharmacology; D013844:Thiazoles / Q000009:adverse effects; D045162:Thiazolidinediones; D000077288:Troglitazone
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001577:Benzophenones; D001969:Bromobenzenes; D002839:Chromans; D007004:Hypoglycemic Agents; D004364:Pharmaceutical Preparations; D013844:Thiazoles; D045162:Thiazolidinediones; C053083:bromfenac; D000077288:Troglitazone